Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation (Q33183745)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
scientific article

    Statements

    Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation (English)
    Joost W J van Esser
    Ellen Meijer
    Jan Willem Gratama
    Leo F Verdonck
    Jan J Cornelissen
    4364-4369

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit